34 related articles for article (PubMed ID: 9543692)
1. BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysis.
Foré R; Liozon E; Dumonteil S; Sené T; Héron E; Lacombe V; Leclercq M; Magnant J; Beuvon C; Régent A; de Mornac D; Samson M; Smets P; Alexandra JF; Granel B; Robert PY; Curumthaullee MF; Parreau S; Palat S; Bezanahary H; Ly KH; Fauchais AL; ; Gondran G
Joint Bone Spine; 2024 Jan; 91(1):105641. PubMed ID: 37734440
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves' orbitopathy.
Shen L; Ye L; Zhu W; Jiao Q; Zhou Y; Wang S; Wang W; Ning G
Eur Thyroid J; 2022 Oct; 11(5):. PubMed ID: 35900774
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital.
Tolou-Ghamari Z; Shaygannejad V; Ashtari F
Int J Prev Med; 2013 May; 4(Suppl 2):S274-8. PubMed ID: 23776737
[TBL] [Abstract][Full Text] [Related]
4. Dose of intravenous steroids and therapy outcome in Graves' orbitopathy.
Zang S; Ponto KA; Pitz S; Kahaly GJ
J Endocrinol Invest; 2011 Dec; 34(11):876-80. PubMed ID: 22322535
[TBL] [Abstract][Full Text] [Related]
5. Thyroid-associated orbitopathy.
Alsuhaibani AH; Nerad JA
Semin Plast Surg; 2007 Feb; 21(1):65-73. PubMed ID: 20567660
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatments for thyroid eye disease.
Modjtahedi SP; Modjtahedi BS; Mansury AM; Selva D; Douglas RS; Goldberg RA; Leibovitch I
Drugs; 2006; 66(13):1685-700. PubMed ID: 16978034
[TBL] [Abstract][Full Text] [Related]
7. Does radiotherapy have a role in the management of thyroid orbitopathy? View 1.
Cockerham KP; Kennerdell JS
Br J Ophthalmol; 2002 Jan; 86(1):102-4. PubMed ID: 11801513
[No Abstract] [Full Text] [Related]
8. Immunosuppressive treatment of Graves' ophthalmopathy.
Wiersinga WM
Thyroid; 1992; 2(3):229-33. PubMed ID: 1422236
[TBL] [Abstract][Full Text] [Related]
9. Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy.
Matejka G; Vergès B; Vaillant G; Petit JM; Brun-Pacaud A; Rudoni S; Brun JM
Horm Metab Res; 1998 Feb; 30(2):93-8. PubMed ID: 9543692
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
11. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
[TBL] [Abstract][Full Text] [Related]
12. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M
Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
Brauer VF; Scholz GH
Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
